Pharmaceuticals & Biotech.    
SECTOR | 05 Jul 2020, 11:25AM
Business Line
WHO's interim trial results showed that the drugs produce little or no reduction in the mortality of hospitalized Covid-19 patients
Pharmaceuticals & Biotech.    
SECTOR | 04 Jul 2020, 09:01AM
Business Standard
Revised guidelines on home isolation of very mildly symptomatic, pre-symptomatic and asymptomatic patients supersede the order issued earlier
default
Pharmaceuticals & Biotech.    
SECTOR | 03 Jul 2020, 07:52PM
No immediate disruption seen by pharma firms from worsening Sino-Indian ties
No immediate disruption seen by pharma firms from worsening Sino-Indian ties
livemint
Pharma companies have been lately keeping bigger inventories to avoid another lockdown-like disruption
Pharmaceuticals & Biotech.    
SECTOR | 03 Jul 2020
DCGI gives nod to Mylan labs to manufacture remdesivir
DCGI gives nod to Mylan labs to manufacture remdesivir
livemint
Gilead had signed non-exclusive voluntary licensing agreements with five generic pharma firms
Pharmaceuticals & Biotech.    
SECTOR | 30 Jun 2020
UK OKs resumption of hydroxychloroquine trial
UK OKs resumption of hydroxychloroquine trial
Moneycontrol
The Medicines and Healthcare Products Regulatory Agency had suspended enrollment into the trial after a paper was published in the journal Lancet last month that suggested there was an increased death risk linked to the drug. The paper was found to be based on fraudulent data and was retracted.
Pharmaceuticals & Biotech.    
SECTOR | 26 Jun 2020
Business Line
The European Medicines Agency (EMA) on Thursday said its human medicines committee (CHMP) has recommended the emergency use of anti-viral treatment Re
Pharmaceuticals & Biotech.    
SECTOR | 26 Jun 2020
NDTV Profit
India relies on China for products such as electronic components and drug ingredients because it cannot make them or source them elsewhere as cheaply, company and industry figures say.
default
Pharmaceuticals & Biotech.    
SECTOR | 20 Jun 2020
Business Today
This site has received valid certifications from the Food and Drug Administration (FDA) as well as the European Medicines Agency (EMA)
Pharmaceuticals & Biotech.    
SECTOR | 13 Jun 2020
Business Today
Four companies -- Hetero, Jubilant Life Sciences, Cipla and Mylan NV -- with which the original drug maker, Gilead Sciences Inc, have entered into non-exclusive licensing agreements are still awaiting nod from the DCGI for manufacturing and selling of remdesivir in India
Pharmaceuticals & Biotech.    
SECTOR | 12 Jun 2020
US approves Biocon-Mylan's version of insulin glargine, companies working on interchangeability
US approves Biocon-Mylan's version of insulin glargine, companies working on interchangeability
Moneycontrol
Biocon-Mylan's Semglee is identical to Sanofi's Lantus and is approved for the same indications.
default